Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion type Assertion NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_head.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion description "[Here we demonstrate in models of lung adenocarcinoma harboring the oncogenic fusion of ALK and EML4 that the GTPase RAS-mitogen-activated protein kinase (MAPK) pathway, but not other known ALK effectors, is required for tumor-cell survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_provenance.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion evidence source_evidence_literature NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_provenance.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion SIO_000772 26301689 NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_provenance.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion wasDerivedFrom befree-2016 NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_provenance.
- NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_assertion wasGeneratedBy ECO_0000203 NP1293116.RAJtjMVBeHoaGPBqIPEd7D4YqSvEsuWNSwLxyRNRlfxTU130_provenance.